ScinoPharm Taiwan Ltd (1789) - Financial and Strategic SWOT Analysis Review

  • ID: 4372842
  • SWOT Analysis
  • Region: Taiwan
  • 38 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • BASF SE
  • JHL Biotech Inc
  • Royal DSM NV
  • Savior Lifetec Corp
  • SCI Pharmtech Inc
  • Synmosa Biopharma Corp
  • MORE
ScinoPharm Taiwan Ltd (1789) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

ScinoPharm Taiwan Ltd (ScinoPharm) provides process research and development (R&D) and active pharmaceutical ingredient (API) manufacturing services to the pharmaceutical industry worldwide. It provides services such as custom synthesis for early phase pharmaceutical activities to brand companies and APIs for the generic industry. The company also provides contract research and manufacturing services (CRAM) services including chemistry skill, analytical and regulatory services, chemical process development, clinical drug substances, exploratory process research and consulting services. ScinoPharm’s wholly owned subsidiaries include SPT International, Ltd., and ScinoPharm Singapore Pte Ltd. The company has research and manufacturing facilities in Taiwan and China. ScinoPharm is headquartered in Tainan, Taiwan.

ScinoPharm Taiwan Ltd Key Recent Developments

Feb 23, 2018: ScinoPharm Reports Financial Performance for 2017
Feb 15, 2017: ScinoPharm Reports Financial Performance for 2016

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • BASF SE
  • JHL Biotech Inc
  • Royal DSM NV
  • Savior Lifetec Corp
  • SCI Pharmtech Inc
  • Synmosa Biopharma Corp
  • MORE
Section 1 - About the Company
  • ScinoPharm Taiwan Ltd - Key Facts
  • ScinoPharm Taiwan Ltd - Key Employees
  • ScinoPharm Taiwan Ltd - Key Employee Biographies
  • ScinoPharm Taiwan Ltd - Major Products and Services
  • ScinoPharm Taiwan Ltd - History
  • ScinoPharm Taiwan Ltd - Company Statement
  • ScinoPharm Taiwan Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • ScinoPharm Taiwan Ltd - Business Description
  • ScinoPharm Taiwan Ltd - Corporate Strategy
  • ScinoPharm Taiwan Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • ScinoPharm Taiwan Ltd - Strengths
  • ScinoPharm Taiwan Ltd - Weaknesses
  • ScinoPharm Taiwan Ltd - Opportunities
  • ScinoPharm Taiwan Ltd - Threats
  • ScinoPharm Taiwan Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • ScinoPharm Taiwan Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • ScinoPharm Taiwan Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • ScinoPharm Taiwan Ltd, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Feb 23, 2018: ScinoPharm Reports Financial Performance for 2017
  • Feb 15, 2017: ScinoPharm Reports Financial Performance for 2016
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • ScinoPharm Taiwan Ltd, Key Facts
  • ScinoPharm Taiwan Ltd, Key Employees
  • ScinoPharm Taiwan Ltd, Key Employee Biographies
  • ScinoPharm Taiwan Ltd, Major Products and Services
  • ScinoPharm Taiwan Ltd, History
  • ScinoPharm Taiwan Ltd, Other Locations
  • ScinoPharm Taiwan Ltd, Subsidiaries
  • ScinoPharm Taiwan Ltd, Key Competitors
  • ScinoPharm Taiwan Ltd, Ratios based on current share price
  • ScinoPharm Taiwan Ltd, Annual Ratios
  • ScinoPharm Taiwan Ltd, Annual Ratios
  • ScinoPharm Taiwan Ltd, Annual Ratios
  • ScinoPharm Taiwan Ltd, Interim Ratios
  • ScinoPharm Taiwan Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • ScinoPharm Taiwan Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • ScinoPharm Taiwan Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • ScinoPharm Taiwan Ltd, Performance Chart (2013 - 2017)
  • ScinoPharm Taiwan Ltd, Ratio Charts
  • ScinoPharm Taiwan Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • ScinoPharm Taiwan Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • JHL Biotech Inc
  • SCI Pharmtech Inc
  • Taiwan Biotech Co Ltd
  • Royal DSM NV
  • BASF SE
  • Teva Pharmaceutical Industries Ltd
  • Savior Lifetec Corp
  • Synmosa Biopharma Corp
  • Zhejiang Huahai Pharmaceutical Co Ltd
  • Guilin Hwasun Pharmaceutical Co Ltd
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll